News
Venmax Drugs & Pharmaceuticals standalone net profit rises 500.00% in the September 2026 quarter
12-Nov-2026 | 17:48
Sales rise 300.00% to Rs 5.28 crore
Net profit of Venmax Drugs & Pharmaceuticals rose 500.00% to Rs 0.12 crore in the quarter ended September 2026 as against Rs 0.02 crore during the previous quarter ended September 2025. Sales rose 300.00% to Rs 5.28 crore in the quarter ended September 2026 as against Rs 1.32 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 5.28 | 1.32 | 300 |
| OPM % | 3.79 | 3.03 | - |
| PBDT | 0.20 | 0.04 | 400 |
| PBT | 0.20 | 0.04 | 400 |
| NP | 0.12 | 0.02 | 500 |
Powered by Capital Market - Live News